Patents Assigned to 1C TARGETS AS
  • Magnetic resonance imaging
    Patent number: 10869938
    Abstract: A method of determining the amount of intracellular manganese in the myocardium of an individual pre-administered with a manganese contrast agent, or a pharmaceutically acceptable salt thereof, comprising subjecting, the individual to a MRI procedure to assess the signal intensity (SI) of images, or more preferably the longitudinal relaxation rate, R1 throughout the myocardium.
    Type: Grant
    Filed: January 18, 2008
    Date of Patent: December 22, 2020
    Assignee: 1C TARGETS AS
    Inventors: Per Jynge, Arne Skjold, Henrik W. Larsson